Amin, K.M.; El-Badry, O.M.; Abdel Rahman, D.E.; Abdellattif, M.H.; Abourehab, M.A.S.; El-Maghrabey, M.H.; Elsaid, F.G.; El Hamd, M.A.; Elkamhawy, A.; Ammar, U.M.
Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties. Pharmaceutics 2022, 14, 1954.
https://doi.org/10.3390/pharmaceutics14091954
AMA Style
Amin KM, El-Badry OM, Abdel Rahman DE, Abdellattif MH, Abourehab MAS, El-Maghrabey MH, Elsaid FG, El Hamd MA, Elkamhawy A, Ammar UM.
Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties. Pharmaceutics. 2022; 14(9):1954.
https://doi.org/10.3390/pharmaceutics14091954
Chicago/Turabian Style
Amin, Kamelia M., Ossama M. El-Badry, Doaa E. Abdel Rahman, Magda H. Abdellattif, Mohammed A. S. Abourehab, Mahmoud H. El-Maghrabey, Fahmy G. Elsaid, Mohamed A. El Hamd, Ahmed Elkamhawy, and Usama M. Ammar.
2022. "Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties" Pharmaceutics 14, no. 9: 1954.
https://doi.org/10.3390/pharmaceutics14091954
APA Style
Amin, K. M., El-Badry, O. M., Abdel Rahman, D. E., Abdellattif, M. H., Abourehab, M. A. S., El-Maghrabey, M. H., Elsaid, F. G., El Hamd, M. A., Elkamhawy, A., & Ammar, U. M.
(2022). Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties. Pharmaceutics, 14(9), 1954.
https://doi.org/10.3390/pharmaceutics14091954